Your browser doesn't support javascript.
loading
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
John, Nevin A; Solanky, Bhavana S; De Angelis, Floriana; Parker, Richard A; Weir, Christopher J; Stutters, Jonathan; Carrasco, Ferran Prados; Schneider, Torben; Doshi, Anisha; Calvi, Alberto; Williams, Thomas; Plantone, Domenico; Monteverdi, Anita; MacManus, David; Marshall, Ian; Barkhof, Frederik; Gandini Wheeler-Kingshott, Claudia A M; Chataway, Jeremy.
Afiliação
  • John NA; Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia.
  • Solanky BS; Department of Neurology, Monash Health, Melbourne, Australia.
  • De Angelis F; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Parker RA; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Weir CJ; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Stutters J; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Carrasco FP; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Schneider T; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Doshi A; Centre for Medical Image Computing (CMIC), University College London, London, UK.
  • Calvi A; e-Health Center, Universitat Oberta de Catalunya, Barcelona, Spain.
  • Williams T; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Plantone D; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Monteverdi A; Laboratory of Advanced Imaging in Neuroimmunological Diseases (imaginEM), Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi I Sunyer (FRCB-IDIBAPS), Barcelona, Spain.
  • MacManus D; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Marshall I; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Barkhof F; Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
  • Gandini Wheeler-Kingshott CAM; Brain Connectivity Center, C. Mondino National Neurological Institute, Pavia, Italy.
  • Chataway J; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
J Magn Reson Imaging ; 2023 Oct 03.
Article em En | MEDLINE | ID: mdl-37787109
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Magn Reson Imaging Assunto da revista: DIAGNOSTICO POR IMAGEM Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Magn Reson Imaging Assunto da revista: DIAGNOSTICO POR IMAGEM Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália